Part,  Chapter, Paragraph

 1   II,     5.  2.  7|    Greenland P, Manheim LM, Dyer AR, Wang R, Lubitz J et al (
 2   II,     5.  2.  7|      Stamler J,. Neaton JD, Dyer AR,. Garside DB, and. Wilson
 3   II,     5.  2.  7|         720-32.~Hozawa A, Folsom AR, Sharrett AR, Chambless
 4   II,     5.  2.  7|    Hozawa A, Folsom AR, Sharrett AR, Chambless LE (2007): Absolute
 5   II,     5.  5.  3| Baden-Baden: Nomos-Verlag.~Chade AR, Kasten M, Tanner CM (2006):
 6   II,     5.  9.Acr|     Insights & Reality in Europe~AR~Atopic Rhinitis~ARIA~Allergic
 7   II,     5.  9.  1|      2006).~ ~Allergic rhinitis (AR) is clinically defined as
 8   II,     5.  9.  1|          or following treatment. AR is associated with impairments
 9   II,     5.  9.  1|         general population while AR is estimated to affect 10–
10   II,     5.  9.  1|        affect 10–30%. Asthma and AR are often co-morbid diseases
11   II,     5.  9.  1|    extent that the prevalence of AR among asthmatic patients
12   II,     5.  9.  1|        the symptomatic burden of AR in patients with asthma,
13   II,     5.  9.  1|         in patients with asthma, AR can complicate asthma management
14   II,     5.  9.  1|      with asthma and concomitant AR compared to those with asthma
15   II,     5.  9.  2|         prevalence of asthma and AR for each country were collected
16   II,     5.  9.  3|        common disease. As far as AR prevalence is concerned,
17   II,     5. 10.  7|      1262-8.~ ~Mills ENC, Mackie AR, Burney P, Beyer K, Frewer
18   II,     9.  1.  1|          K, Gibson AT, Wilkinson AR (2000): Neurologic and developmental
19   II,     9.  3.  2|          K, Gibson AT, Wilkinson AR (2000): Neurologic and developmental
20  III,    10.  2.  1|             Armstrong J, Dorosty AR, Reilly JJ, Emmett PM, for